Best TWAS P=3.65e-14 · Best GWAS P=1.95e-20 conditioned to 1.2e-08
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Testis | ATF6 | 0.23 | 0.08 | lasso | 6 | 0.05 | 3.3e-03 | 9.3 | -7.2 | 4.2e-13 | -0.85 | 0.00 | 0.97 | FALSE |
2 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | ITLN1 | 0.04 | 0.04 | lasso | 1 | 0.03 | 2.6e-04 | -5.1 | 5.1 | 2.8e-07 | 0.01 | 0.02 | 0.88 | FALSE |
3 | The Cancer Genome Atlas | Brain Lower Grade Glioma | CD244 | 0.05 | 0.05 | lasso | 2 | 0.05 | 3.2e-06 | -5.2 | -5.2 | 2.1e-07 | -0.03 | 0.07 | 0.93 | FALSE |
4 | The Cancer Genome Atlas | Lung Adenocarcinoma | CD244 | 0.03 | 0.00 | blup | 59 | 0.02 | 5.7e-04 | -4.8 | -5.1 | 2.7e-07 | -0.03 | 0.07 | 0.82 | FALSE |
5 | The Cancer Genome Atlas | Lung Adenocarcinoma | ITLN1 | 0.04 | 0.04 | lasso | 2 | 0.04 | 1.5e-05 | -5.6 | 5.4 | 6.4e-08 | 0.01 | 0.01 | 0.98 | FALSE |
6 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | FCGR2A | 0.17 | 0.08 | enet | 5 | 0.16 | 2.3e-07 | 7.5 | -7.6 | 3.7e-14 | -0.64 | 0.05 | 0.87 | TRUE |
7 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | FCGR3A | 0.08 | 0.02 | blup | 18 | 0.03 | 3.0e-02 | 3.7 | -5.4 | 6.6e-08 | -0.42 | 0.01 | 0.23 | FALSE |
8 | The Cancer Genome Atlas | Thyroid Carcinoma | CD244 | 0.03 | 0.03 | lasso | 2 | 0.03 | 3.2e-04 | -5.2 | -5.4 | 7.3e-08 | -0.01 | 0.04 | 0.79 | FALSE |
9 | The Cancer Genome Atlas | Thyroid Carcinoma | ITLN1 | 0.05 | 0.03 | enet | 3 | 0.03 | 4.4e-04 | -4.8 | 5.6 | 2.8e-08 | -0.01 | 0.01 | 0.86 | FALSE |
10 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | ITLN1 | 0.13 | 0.13 | lasso | 1 | 0.13 | 2.2e-04 | -5.7 | 5.7 | 1.1e-08 | 0.01 | 0.01 | 0.91 | TRUE |